Serum PCT has been considered as one of the main biomarkers of bacterial infection, which could be incorporated into decision-supporting and prognostic algorithms for the management of lower respiratory tract infections [16]. This evidence concerns the gene CALCA and Recurrent lower respiratory tract infections.